Journal for ImmunoTherapy of Cancer (Feb 2022)
Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the phase III IMpower150 trial
- Eugene Kim,
- Federico Cappuzzo,
- Martin Reck,
- Wei Zou,
- Mark A Socinski,
- Mark McCleland,
- Makoto Nishio,
- Stefanie Morris,
- David Shames,
- Meghna Das Thakur,
- Tony SK Mok,
- Howard Jack West,
- Robert M Jotte,
- Geetha Shankar
Affiliations
- Eugene Kim
- Department of Anesthesiology and Critical Care Medicine, Children`s Hospital of Los Angeles, Los Angeles, California, USA
- Federico Cappuzzo
- Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy
- Martin Reck
- Lungen Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
- Wei Zou
- Department of Biostatistics Oncology, Genentech Inc, South San Francisco, California, USA
- Mark A Socinski
- Thoracic Oncology, AdventHealth Cancer Institute, Orlando, Florida, USA
- Mark McCleland
- Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA
- Makoto Nishio
- Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
- Stefanie Morris
- Product Development Medical Affairs Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- David Shames
- Genentech Inc, South San Francisco, California, USA
- Meghna Das Thakur
- Department of Development Sciences, Genentech, San Francisco, California, USA
- Tony SK Mok
- 15Clinical Oncology, State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong, China
- Howard Jack West
- Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA
- Robert M Jotte
- Department of Medical Oncology, Rocky Mountain Cancer Centers, Denver, Colorado, USA
- Geetha Shankar
- Genentech Inc, South San Francisco, California, USA
- DOI
- https://doi.org/10.1136/jitc-2021-003027
- Journal volume & issue
-
Vol. 10,
no. 2
Abstract
No abstracts available.